|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-1-3
|
|
pubmed:abstractText |
To project the long-term clinical and economic outcomes of treatment with biphasic insulin aspart 30 (BIAsp 70/30, 30% soluble and 70% protaminated insulin aspart) vs. insulin glargine in insulin-naïve type 2 diabetes patients failing to achieve glycemic control with oral antidiabetic agents alone (OADs).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biphasic Insulins,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Isophane,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Long-Acting,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin Aspart,
http://linkedlifedata.com/resource/pubmed/chemical/glargine,
http://linkedlifedata.com/resource/pubmed/chemical/insulin aspart, insulin aspart...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1462-8902
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
103-13
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17199725-Administration, Oral,
pubmed-meshheading:17199725-Adult,
pubmed-meshheading:17199725-Aged,
pubmed-meshheading:17199725-Biphasic Insulins,
pubmed-meshheading:17199725-Cost-Benefit Analysis,
pubmed-meshheading:17199725-Diabetes Complications,
pubmed-meshheading:17199725-Diabetes Mellitus, Type 2,
pubmed-meshheading:17199725-Epidemiologic Methods,
pubmed-meshheading:17199725-Female,
pubmed-meshheading:17199725-Health Care Costs,
pubmed-meshheading:17199725-Hemoglobin A, Glycosylated,
pubmed-meshheading:17199725-Humans,
pubmed-meshheading:17199725-Hypoglycemic Agents,
pubmed-meshheading:17199725-Insulin,
pubmed-meshheading:17199725-Insulin, Isophane,
pubmed-meshheading:17199725-Insulin, Long-Acting,
pubmed-meshheading:17199725-Insulin Aspart,
pubmed-meshheading:17199725-Male,
pubmed-meshheading:17199725-Middle Aged,
pubmed-meshheading:17199725-Treatment Failure,
pubmed-meshheading:17199725-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.
|
|
pubmed:affiliation |
CORE - Center for Outcomes Research, A unit of IMS, Binningen/Basel, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
